Michael Henry Fiore Sells 2,470 Shares of HealthEquity (NASDAQ:HQY) Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Michael Henry Fiore sold 2,470 shares of the firm’s stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $95.00, for a total value of $234,650.00. Following the completion of the sale, the executive vice president directly owned 56,643 shares in the company, valued at approximately $5,381,085. This represents a 4.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Michael Henry Fiore also recently made the following trade(s):

• On Friday, May 29th, Michael Henry Fiore sold 3,142 shares of HealthEquity stock. The stock was sold at an average price of $95.00, for a total value of $298,490.00.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $94.73 on Thursday. The business has a 50 day moving average price of $86.93 and a 200 day moving average price of $84.60. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $105.96. The company has a market cap of $7.92 billion, a price-to-earnings ratio of 35.48, a PEG ratio of 1.63 and a beta of 0.21. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Institutional Trading of HealthEquity

Several institutional investors have recently made changes to their positions in the business. Acumen Wealth Advisors LLC bought a new stake in HealthEquity in the fourth quarter valued at about $27,000. Aster Capital Management DIFC Ltd bought a new position in HealthEquity during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd lifted its stake in HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after purchasing an additional 293 shares during the period. Leonteq Securities AG boosted its holdings in HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after purchasing an additional 235 shares in the last quarter. Finally, Axiom Investment Management LLC bought a new stake in shares of HealthEquity in the 1st quarter valued at approximately $33,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently issued reports on HQY. JPMorgan Chase & Co. dropped their price objective on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a report on Wednesday, March 18th. Citigroup restated a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. BMO Capital Markets raised HealthEquity from a “market perform” rating to an “outperform” rating and upped their price target for the company from $85.00 to $105.00 in a report on Thursday, April 9th. Barrington Research reiterated an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a research report on Friday, May 22nd. Finally, Wall Street Zen lowered HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, July 4th. Eleven research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $110.57.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.